FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2271859417> ?p ?o ?g. }

• W2271859417 endingPage "1670" @default.
• W2271859417 startingPage "1661" @default.
• W2271859417 abstract "Head and neck squamous cell carcinoma (HNSCC) is a malignancy with an increasing incidence. To aid with the selection of the most appropriate therapy, biomarkers have become a specific research focus. Sec62 is involved in endoplasmic reticulum stress tolerance and cell migration, and has been identified as a novel prognostic marker for non‑small cell lung cancer. In addition, Sec62 may be a promising candidate in HNSCC. Pretreatment biopsies of 35 patients with locally advanced HNSCC, who were treated with definitive chemoradiation therapy without prior surgery, were examined for the expression of Sec62 protein, as well as the expression of epidermal growth factor receptor (EGFR), p16 and survivin proteins. Immunohistological results were correlated with patient overall survival (OS) and progression‑free survival (PFS) times. In the present patient cohort, 12/35 cases (34%) demonstrated strong and 8/35 cases (23%) moderate Sec62 staining intensity. Additionally, in 11/35 cases (31%), weak staining was observed, and only 4/35 cases (11%) were Sec62‑negative. Notably, a high Sec62 protein level was associated with a significantly poorer OS and PFS (P=0.020 and P=0.028, respectively). Furthermore, higher nuclear survivin expression showed a weak trend for poorer OS rate (P=0.079), whilst neither cytoplasmic survivin, EGFR nor p16 influenced OS or PFS significantly. The present study indicated that Sec62 is a promising prognostic marker for HNSCC. Increased Sec62 protein expression may indicate a poorer prognosis in advanced HNSCC. As the present study was focused on patients treated by chemoradiation therapy, further studies with larger patient cohorts and alternative treatment approaches are required in order to define the prognostic value of Sec62 in HNSCC." @default.
• W2271859417 created "2016-06-24" @default.
• W2271859417 creator A5000520680 @default.
• W2271859417 creator A5026546434 @default.
• W2271859417 creator A5028259455 @default.
• W2271859417 creator A5039482910 @default.
• W2271859417 creator A5049240652 @default.
• W2271859417 creator A5074060834 @default.
• W2271859417 creator A5079158573 @default.
• W2271859417 date "2016-01-20" @default.
• W2271859417 modified "2023-10-16" @default.
• W2271859417 title "Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma" @default.
• W2271859417 cites W1535352090 @default.
• W2271859417 cites W1662899239 @default.
• W2271859417 cites W1838340609 @default.
• W2271859417 cites W1919011139 @default.
• W2271859417 cites W1972635603 @default.
• W2271859417 cites W1973121335 @default.
• W2271859417 cites W1982573893 @default.
• W2271859417 cites W1984467395 @default.
• W2271859417 cites W1996098543 @default.
• W2271859417 cites W1997152230 @default.
• W2271859417 cites W1999031532 @default.
• W2271859417 cites W2000859982 @default.
• W2271859417 cites W2002439304 @default.
• W2271859417 cites W2009925718 @default.
• W2271859417 cites W2011391342 @default.
• W2271859417 cites W2017261026 @default.
• W2271859417 cites W2021190269 @default.
• W2271859417 cites W2021263074 @default.
• W2271859417 cites W2026483006 @default.
• W2271859417 cites W2030254527 @default.
• W2271859417 cites W2033692227 @default.
• W2271859417 cites W2035523654 @default.
• W2271859417 cites W2036926586 @default.
• W2271859417 cites W2042571217 @default.
• W2271859417 cites W2051120695 @default.
• W2271859417 cites W2059741401 @default.
• W2271859417 cites W2075816930 @default.
• W2271859417 cites W2080924552 @default.
• W2271859417 cites W2096136039 @default.
• W2271859417 cites W2099273077 @default.
• W2271859417 cites W2101960909 @default.
• W2271859417 cites W2102282815 @default.
• W2271859417 cites W2106787323 @default.
• W2271859417 cites W2110664940 @default.
• W2271859417 cites W2114000644 @default.
• W2271859417 cites W2127605299 @default.
• W2271859417 cites W2128327076 @default.
• W2271859417 cites W2128655510 @default.
• W2271859417 cites W2130370138 @default.
• W2271859417 cites W2131971625 @default.
• W2271859417 cites W2132813978 @default.
• W2271859417 cites W2135247615 @default.
• W2271859417 cites W2135619026 @default.
• W2271859417 cites W2138526447 @default.
• W2271859417 cites W2139766596 @default.
• W2271859417 cites W2140252749 @default.
• W2271859417 cites W2145478177 @default.
• W2271859417 cites W2145738531 @default.
• W2271859417 cites W2148818765 @default.
• W2271859417 cites W2149139293 @default.
• W2271859417 cites W2149347081 @default.
• W2271859417 cites W2161959295 @default.
• W2271859417 cites W2171505448 @default.
• W2271859417 cites W2182788714 @default.
• W2271859417 cites W2288483565 @default.
• W2271859417 cites W2340386540 @default.
• W2271859417 doi "https://doi.org/10.3892/ol.2016.4135" @default.
• W2271859417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4774472" @default.
• W2271859417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26998059" @default.
• W2271859417 hasPublicationYear "2016" @default.
• W2271859417 type Work @default.
• W2271859417 sameAs 2271859417 @default.
• W2271859417 citedByCount "32" @default.
• W2271859417 countsByYear W22718594172016 @default.
• W2271859417 countsByYear W22718594172017 @default.
• W2271859417 countsByYear W22718594172018 @default.
• W2271859417 countsByYear W22718594172019 @default.
• W2271859417 countsByYear W22718594172020 @default.
• W2271859417 countsByYear W22718594172021 @default.
• W2271859417 countsByYear W22718594172022 @default.
• W2271859417 countsByYear W22718594172023 @default.
• W2271859417 crossrefType "journal-article" @default.
• W2271859417 hasAuthorship W2271859417A5000520680 @default.
• W2271859417 hasAuthorship W2271859417A5026546434 @default.
• W2271859417 hasAuthorship W2271859417A5028259455 @default.
• W2271859417 hasAuthorship W2271859417A5039482910 @default.
• W2271859417 hasAuthorship W2271859417A5049240652 @default.
• W2271859417 hasAuthorship W2271859417A5074060834 @default.
• W2271859417 hasAuthorship W2271859417A5079158573 @default.
• W2271859417 hasBestOaLocation W22718594171 @default.
• W2271859417 hasConcept C121608353 @default.
• W2271859417 hasConcept C126322002 @default.
• W2271859417 hasConcept C142724271 @default.
• W2271859417 hasConcept C143998085 @default.
• W2271859417 hasConcept C204232928 @default.
• W2271859417 hasConcept C2775975398 @default.

• next